Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Premature Ejaculation — Causes, Symptoms & Treatment Guide — Symptoms, Causes & Treatment | MyMedicPlus

Updated: 2026-07-06
Ad — after-intro

Quick Facts

Type
Male sexual health / Urology
Specialist
GP / Urologist / Andrologist / Sexual Health Specialist
Key Treatment
Behavioural techniques (stop-start, squeeze); topical lidocaine/prilocaine spray; dapoxetine 30-60mg on-demand (licensed SSRI); daily SSRIs (paroxetine, sertraline — off-label); treat erectile dysfunction if comorbid
Prevalence
Affects 20-30% of adult men across all age groups; most common male sexual complaint globally; often under-reported due to embarrassment and stigma; affects approximately 100-150 million men

Overview: Premature Ejaculation

Premature ejaculation (PE) is the most common male sexual dysfunction, characterised by ejaculation that consistently occurs sooner than desired — typically within 1-2 minutes of vaginal penetration — with minimal voluntary control, causing personal distress, frustration, or interpersonal difficulties. The International Society for Sexual Medicine (ISSM) distinguishes: Lifelong (primary) PE — consistent from first sexual experience, likely neurobiological (genetic serotonin pathway variants); Acquired (secondary) PE — develops after a period of normal ejaculatory control (often triggered by erectile dysfunction, relationship issues, anxiety, or medical causes). PE affects 20-30% of adult men and is the most prevalent male sexual complaint globally. It carries significant psychological burden — reduced sexual confidence, performance anxiety, avoidance of intimacy, and relationship strain. With appropriate treatment — behavioural techniques, pharmacotherapy, or combined approaches — the majority of men achieve clinically meaningful improvement.

Causes & Risk Factors

Neurobiological factors: central serotonergic pathways control the timing of ejaculation — low central serotonin activity or reduced 5-HT2C receptor sensitivity lowers the ejaculatory threshold; genetic variants in the serotonin transporter (5-HTTLPR) are associated with lifelong PE. Penile hypersensitivity contributes in some men. Psychological factors: performance anxiety is the most common cause of acquired PE (fear of rapid ejaculation becomes self-fulfilling); early sexual experiences that conditioned rapid ejaculation; stress, depression, and anxiety; negative body image and low sexual self-confidence; partner relationship conflict or communication difficulties; restrictive sexual attitudes. Medical causes of acquired PE: erectile dysfunction (most important — fear of losing erection before ejaculation results in rushing to ejaculate; always treat ED first); hyperthyroidism (increased sympathetic tone); chronic prostatitis/chronic pelvic pain syndrome; urethritis. Recreational drugs and alcohol can impair ejaculatory control. Neurological conditions affecting the sacral reflex arc are rare causes.

Symptoms & Signs

The primary presenting complaint is ejaculation perceived to occur too rapidly — typically within 1-2 minutes of vaginal penetration, or before the man wishes, with little or no voluntary control. Key clinical features: Intravaginal Ejaculatory Latency Time (IELT) — consistently below 1-2 minutes in lifelong PE; shorter than previous 'normal' latency in acquired PE. Inability to delay ejaculation despite trying. Significant personal distress — embarrassment, anxiety, frustration, or avoidance of sexual activity. Relationship impact — partner dissatisfaction, reduced intimacy, and relationship conflict. Performance anxiety — heightened anxiety before and during sexual activity. Classify as: lifelong (from first sexual experience — neurobiological) vs. acquired (new onset — psychological or medical); global (in all sexual situations) vs. situational (only with specific partners or situations); and with or without erectile dysfunction (must be assessed in all men with PE).

Diagnosis & Tests

PE is a clinical diagnosis — no specific investigations are required for uncomplicated cases. Essential history: onset (lifelong vs. acquired), estimated IELT (with or without stopwatch — self-estimated IELT is validated), whether acquired: identify precipitating cause (new partner, anxiety, erectile problems), comorbid erectile dysfunction (the most important assessment — treat ED first), current medications, recreational drug and alcohol use, relationship quality, and emotional wellbeing. Validated questionnaires: Index of Premature Ejaculation (IPE), Premature Ejaculation Diagnostic Tool (PEDT) — score severity and guide treatment. Physical examination: genital examination, neurological assessment if central/peripheral cause suspected, prostate examination if prostatitis suspected. Investigations: thyroid function (TSH) if acquired PE — hyperthyroidism is a reversible cause; urinalysis/MSU if prostatitis suspected; testosterone if comorbid reduced libido; assess for ED with erectile function questionnaire (IIEF). Comorbid erectile dysfunction must always be assessed and treated first — PE secondary to ED often resolves when ED is adequately treated with PDE5 inhibitors.

Treatment Options

Behavioural therapy (most durable long-term benefit): Stop-Start technique (Semans) — penis stimulated to near-ejaculatory threshold, then all stimulation ceases until arousal subsides; repeat 3-4 times per session; gradually trains ejaculatory control. Squeeze technique (Masters and Johnson) — manual pressure applied to the glans/frenulum at near-ejaculation point; immediate suppression of ejaculatory urgency. Sensate focus exercises — reduce performance anxiety through non-demand graduated sexual activities with partner. Pelvic floor muscle training (Kegel exercises): strengthening pubococcygeus muscles — RCT evidence demonstrates meaningful improvement in ejaculatory latency. Topical anaesthetics (applied 10-30 minutes before intercourse, removed before penetration or used in condom): lidocaine 9.6%/prilocaine 2.5% metered-dose spray (EMLA or Fortacin — licensed for PE); lidocaine 5% cream. Reduces glans sensitivity — prolongs IELT by average 4-6 minutes. Pharmacotherapy: Dapoxetine (30mg or 60mg taken 1-3 hours before intercourse): only licensed on-demand oral PE treatment; short-acting SSRI; delays ejaculation 2-3 fold; on-demand use avoids need for daily medication; approved in many countries. Daily SSRIs (off-label): paroxetine 10-40mg (most potent — average 8x IELT increase), clomipramine, sertraline 50mg; takes 1-2 weeks for full effect; taken daily regardless of sexual activity. Combination (topical + dapoxetine, or pharmacotherapy + behavioural) achieves best outcomes for moderate-severe PE. Treat ED first with PDE5 inhibitors (sildenafil, tadalafil) — often resolves acquired PE secondary to ED.

Complications

Premature ejaculation (PE) causes significant psychological and relational complications, even though it carries no direct physical health risks. Psychological complications affect the majority of men with lifelong PE — anxiety about sexual performance (anticipatory anxiety before sexual encounters), shame, reduced self-esteem, depression, and sexual avoidance are prevalent; approximately 40-60% of men with PE report clinically significant psychological distress. Partner sexual dissatisfaction is a major consequence — many partners of men with PE experience their own sexual dysfunction (arousal difficulties, anorgasmia, pain from insufficient arousal) and frustration, contributing to relationship conflict, reduced intimacy, and relationship breakdown. The avoidance cycle — anxiety causing PE, leading to avoidance, increasing anxiety — entrenches the condition over time. In men where PE is secondary to erectile dysfunction (erection problems causing rush to ejaculate), the underlying ED must be addressed first — untreated ED perpetuates acquired PE. Secondary depression affects men with long-term unresolved PE, with emotional impact extending beyond sexual encounters to general mood, self-image, and relationships. Where PE is secondary to prostatitis or hyperthyroidism, the underlying condition causes its own complications if untreated. Paradoxically, overcorrection with high-dose SSRIs or topical anaesthetics can cause delayed ejaculation or anorgasmia — creating the opposite problem. Couple relationship dissolution is reported in 10-15% of couples where PE is severe and prolonged.

Prevention & Lifestyle Management

Open communication with your partner is the most effective non-medical intervention — performance anxiety driven by fear of disappointing a partner is the most common acquired PE perpetuator. Couples who communicate openly about sexual needs and expectations have significantly better PE outcomes. Pelvic floor exercises (Kegel exercises) — daily squeezing and releasing pubococcygeus muscles — should be maintained as long-term practice; reduces ejaculatory urgency. The 'stop-start' behavioural technique practised regularly (including during masturbation) builds lasting ejaculatory control. Masturbating 2-4 hours before partnered sex reduces arousal level and can delay ejaculation. Condoms reduce penile sensitivity and may delay ejaculation in mild PE. Manage comorbid anxiety and depression — both aggravate PE; effective psychological treatment or SSRI therapy addresses both simultaneously. Limit alcohol and recreational drug use — both impair ejaculatory control and sexual confidence. Avoid pornography-driven expectations about ejaculatory timing which are neither typical nor realistic.

When to Seek Medical Attention

See your GP or a men's health or sexual health specialist if premature ejaculation is causing personal distress, relationship strain, or avoidance of sexual activity. PE is a common medical condition — effective treatments are available. Do not suffer in isolation or assume the situation cannot improve. Early treatment is preferable — PE rarely resolves spontaneously without specific intervention, and the avoidance behaviours it causes tend to worsen anxiety and relationship difficulties over time. See a doctor promptly for acquired PE (new onset) — particularly if it is accompanied by erectile difficulties, urinary symptoms, or pelvic pain. Both partners benefit from attending assessment and treatment together. A GP can initiate treatment (topical anaesthetics, dapoxetine) or refer to a urologist, andrologist, or sexual health specialist for specialist input or psychosexual therapy.

Frequently Asked Questions

PE has both physical and psychological components, and their relative importance varies by type. Lifelong (primary) PE — consistent from the first sexual experience — has a predominantly neurobiological basis: central serotonergic pathway variants that lower the ejaculatory threshold appear to be inherited. These men require pharmacological treatment (SSRI, dapoxetine, topical anaesthetic) as the underlying biology cannot be modified by willpower or therapy alone. Acquired (secondary) PE — developing after a period of normal function — is predominantly psychogenic: performance anxiety, erectile dysfunction, relationship conflict, or stress. Behavioural therapy, psychosexual counselling, and treatment of the underlying trigger (particularly ED) are most important. In practice, most cases of PE have mixed physical and psychological contributions — combined treatment (pharmacological + behavioural) is most effective.
Standard premature ejaculation does not affect fertility — sperm are delivered into or near the vaginal canal and can reach the fallopian tubes to fertilise an egg regardless of ejaculatory latency. Fertility is not impaired by the speed of ejaculation. However, in rare extreme cases where ejaculation occurs consistently before vaginal penetration (anejaculation into clothing or very early pre-penetration ejaculation), sperm may not reach the vagina, reducing conception chances with intercourse. In such cases, intrauterine insemination (IUI) with a prepared sperm sample (collected by masturbation) provides an effective solution. Couples experiencing difficulty conceiving where PE is thought to be a factor should undergo standard fertility evaluation — which will assess other potential contributing factors in both partners.
Dapoxetine (Priligy) is a short-acting SSRI specifically designed for on-demand use in PE. It is taken 1-3 hours before anticipated sexual activity (the 1-3 hour window allows flexibility). It achieves peak plasma concentrations within 1-2 hours of ingestion. Clinical trial data show dapoxetine prolongs IELT (ejaculatory latency) by approximately 2-3 fold compared to placebo: median IELT improved from approximately 0.9 minutes at baseline to 2.5-3 minutes on dapoxetine 30mg, and to 3.0-3.5 minutes on 60mg. Approximately 50% of men are satisfied with their response. Dapoxetine is not suitable for daily use — its short half-life (approximately 1.5 hours) means it is cleared rapidly with no next-day effect. Most common side effects: nausea (approximately 11%), headache, dizziness. Avoid in men with mania, severe depression, significant cardiac disease, or taking MAOIs.
Yes — the squeeze technique (and the stop-start technique) have controlled study evidence demonstrating improvement in ejaculatory control, though modern trials show more modest effects than originally claimed by Masters and Johnson. The techniques work by repetitively bringing the man to high arousal states and then reducing stimulation, gradually raising the ejaculatory threshold through a process of learned inhibition and desensitisation. Consistent practice — initially during masturbation, then with a partner — is required. Most men notice meaningful improvement within 4-8 weeks of regular practice (2-3 times per week). The improvement is maintained with continued practice. Behavioural techniques are most effective for acquired PE (where conditioned rapid ejaculation has developed) and psychogenic PE. For lifelong PE with a strong neurobiological basis, pharmacotherapy is typically needed alongside behavioural approaches.

References

  1. Serefoglu EC et al. — An Evidence-Based Unified Definition of Lifelong and Acquired Premature Ejaculation (ISSM), Sexual Medicine 2014
  2. EAU Guidelines on Sexual and Reproductive Health — Premature Ejaculation, European Association of Urology 2024
  3. Althof SE et al. — An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation, Sexual Medicine 2014
Ad — after-content

Medically Reviewed

Our medical content follows strict editorial guidelines to ensure accuracy and reliability.

Up to Date

Last updated: 2026-07-06

Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Connect with top hospitals and specialists. Get personalized guidance for your medical journey.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.